Shanghai Henlius Biotech is driving a quiet revolution in biotechnology from its base in Shanghai. The company recently held an Annual General Meeting, where all resolutions received strong shareholder approval,…
Merck is investing $1 billion in a new biotechnological facility at Chestnut Run Innovation & Science Park in Wilmington, Delaware. The facility will manufacture Keytruda, a leading cancer therapy, significantly…
A small biotech start-up's groundbreaking drug faces an unexpected approval delay from the FDA, highlighting broader regulatory challenges. The delayed drug aims to address a critical health issue affecting millions,…
BB Biotech reported a net loss of 241 million Swiss francs in Q1 2025, compared to a 260 million franc profit last year, due to volatile U.S. pharmaceutical markets and…
The biopharmaceutical industry is central to China's strategic goals, merging economic growth, public welfare, and national security. China shifts from producing generic drugs to innovating in life sciences, competing globally…
Edesa Biotech appoints Peter J. Weiler as Chief Financial Officer starting May 1, 2025, to enhance drug development efforts for immuno-inflammatory diseases. Weiler brings extensive pharmaceutical experience, previously holding key…
Edesa Biotech appoints Peter J. Weiler as Chief Financial Officer, effective May 1, 2025, marking a significant leadership change. Weiler succeeds Stephen Lemieux, who transitions to an advisory role, maintaining…
Wacker Biotech and RNAV8 Bio have embarked on a transformative mRNA technology partnership, aiming to revolutionize medicine. Wacker Biotech brings advanced microbial fermentation capabilities, enhancing pharmaceutical protein and pDNA production.…
Relay Therapeutics is undergoing significant changes with workforce reductions and cost-cutting to focus on clinical ambitions. The company has reduced its annual research budget by 75% and cut 70 jobs…
The pharmaceutical industry's R&D is driven by a competitive pursuit of innovation and breakthroughs. Merck continues its prominence in oncology and vaccines, aiming for long-term impact through strategic R&D investment.…